30.69
Alamar Biosciences Inc Azioni (ALMR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 |
| Durata del periodo | 3 mesi | 3 mesi |
| Revenues |
13.03%
29.43
|
26.04 |
| Cost Of Revenue |
1.13%
11.71
|
11.58 |
| Gross Profit |
22.56%
17.72
|
14.46 |
|
|
16.59%
31.25
|
26.80 |
| Depreciation and Amortization |
2.83%
1.134
|
1.167 |
| Operating Income/Loss |
9.60%
-13.53
|
-12.35 |
| Income/Loss From Continuing Operations Before Tax |
36.28%
-13.29
|
-20.86 |
| Income Tax Expense/Benefit |
120.04%
-0.093
|
0.464 |
| Net Income/Loss |
38.11%
-13.20
|
-21.32 |
| Basic Average Shares |
378.52%
58.67
|
12.26 |
| Diluted Average Shares |
378.52%
58.67
|
12.26 |
| Basic Earnings Per Share |
87.36%
-0.22
|
-1.74 |
| Diluted Earnings Per Share |
87.36%
-0.22
|
-1.74 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):